Ranibizumab Outcomes at 2 Years: Are They Holding Up?

by Medscape • 2012/02/17 • 0 Comments

The 2-year follow-up results are in for intravitreal ranibizumab in the treatment of diabetic macular edema.
Medscape Ophthalmology

← Absorption of Iron from Ferritin Is Independent of Heme Iron and Ferrous Salts in Women and Rat Intestinal Segments.

Riboflavin offers a targeted strategy for managing hypertension in patients with the MTHFR 677TT genotype: a 4-y follow-up →